Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases.
On the company’s earnings call, President and CEO Dave Li said the quarter represented “another strong period of execution and results,” despite global volatility and uncertainty. Ingevity posted first-quarter sales of $258 million, up 4% from the prior-year period, while adjusted EBITDA was $92 million. Adjusted EBITDA margin was 35.5%, compared with 36.8% in the first quarter of 2025.
